...
首页> 外文期刊>Journal of Medicinal Chemistry >Amino Acids Bearing Aromatic or Heteroaromatic Substituents as a New Class of Ligands for the Lysosomal Sialic Acid Transporter Sialin
【24h】

Amino Acids Bearing Aromatic or Heteroaromatic Substituents as a New Class of Ligands for the Lysosomal Sialic Acid Transporter Sialin

机译:氨基酸轴承芳族或杂芳族取代基作为溶酶体唾液酸转运蛋白的新类配体

获取原文
获取原文并翻译 | 示例

摘要

Sialin, encoded by the SLC17A5 gene, is a lysosomal sialic acid transporter defective in Salla disease, a rare inherited leukodystrophy. It also enables metabolic incorporation of exogenous sialic acids, leading to autoantibodies against N-glycolylneuraminic acid in humans. Here, we identified a novel class of human sialin ligands by virtual screening and structure-activity relationship studies. The ligand scaffold is characterized by an amino acid backbone with a free carboxylate, an N-linked aromatic or heteroaromatic substituent, and a hydrophobic side chain. The most potent compound, 45 (LSP12-3129), inhibited N-acetylneuraminic acid 1 (Neu5Ac) transport in a non-competitive manner with IC50 approximate to 2.5 mu M, a value 400-fold lower than the K-M for Neu5Ac. In vitro and molecular docking studies attributed the non-competitive character to selective inhibitor binding to the Neu5Ac site in a cytosol-facing conformation. Moreover, compound 45 rescued the trafficking defect of the pathogenic mutant (R39C) causing Salla disease. This new class of cell-permeant inhibitors provides tools to investigate the physiological roles of sialin and help develop pharmacological chaperones for Salla disease.
机译:由SLC17A5基因编码的Sialin是溶酶体唾液酸转运蛋白在Salla疾病中有缺陷,一种罕见的遗传失育术。它还能够实现外源性唾液酸的代谢掺入,导致人类中对N-甘油酰胺酸的自身抗体。在这里,我们通过虚拟筛选和结构 - 活动关系研究鉴定了一种新型人类唾液酸唾液配体。配体支架的特征在于氨基酸主链,其具有游离羧酸盐,N-连接的芳族或杂芳族取代基和疏水侧链。最有效的化合物45(LSP12-3129)抑制了N-乙酰甘氨酸1(NEU5AC)以非竞争性方式运输,IC50近似为2.5μm,比对于Neu5ac的K-M值低400倍。体外和分子对接研究将非竞争性症状的选择性抑制剂与Neu5Ac位点结合到细胞溶溶胶的构象中。此外,化合物45救出了致病突变体(R39C)的贩运缺陷,导致Salla病。这类新的细胞 - Permeant抑制剂提供了研究Sialin的生理作用,并帮助开发用于Salla病的药理伴侣的工具。

著录项

  • 来源
    《Journal of Medicinal Chemistry 》 |2020年第15期| 共19页
  • 作者单位

    Univ Paris Lab Chim &

    Biochim Pharmacol &

    Toxicol CNRS UMR 8601 F-75006 Paris France;

    PSL Univ Sorbonne Univ Lab Biomol CNRS LBM Ecole Normale Super F-75005 Paris France;

    Univ Paris Lab Chim &

    Biochim Pharmacol &

    Toxicol CNRS UMR 8601 F-75006 Paris France;

    Univ Paris CNRS SPPIN St Peres Paris Inst Neurosci F-75006 Paris France;

    Univ Paris CNRS SPPIN St Peres Paris Inst Neurosci F-75006 Paris France;

    Univ Lille Unite Glycobiol &

    Fonct CNRS UGSF UMR 8576 F-59650 Lille France;

    Univ Paris Lab Chim &

    Biochim Pharmacol &

    Toxicol CNRS UMR 8601 F-75006 Paris France;

    Univ Paris Lab Chim &

    Biochim Pharmacol &

    Toxicol CNRS UMR 8601 F-75006 Paris France;

    Univ Lille Unite Glycobiol &

    Fonct CNRS UGSF UMR 8576 F-59650 Lille France;

    Hosp Civils Lyon Ctr Biol &

    Pathol Est Serv Biochim &

    Biol Mol Grand Est F-69677 Bron France;

    BIOVIA Dassault Syst F-78140 Velizy Villacoublay France;

    BIOVIA Dassault Syst F-78140 Velizy Villacoublay France;

    Univ Paris Lab Chim &

    Biochim Pharmacol &

    Toxicol CNRS UMR 8601 F-75006 Paris France;

    Univ Paris Lab Chim &

    Biochim Pharmacol &

    Toxicol CNRS UMR 8601 F-75006 Paris France;

    Univ Paris CNRS SPPIN St Peres Paris Inst Neurosci F-75006 Paris France;

    Univ Paris CNRS SPPIN St Peres Paris Inst Neurosci F-75006 Paris France;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号